The Trump administration on Tuesday began withholding tens of millions in federal funding from Planned Parenthood and other health-care providers, a move that could reduce access to services including cancer screenings and affordable birth control.
Several arts organizations represented by the American Civil Liberties Union are suing the National Endowment for the Arts over a new policy that aligns with President Donald Trump’s executive order that called for agencies to end federal funding of “gender ideology” and for the federal government to define sex as only male or female.
VA is among the largest employers of federal workers, with most employed operating its network of hospitals around the country, according to Pew Research Center.
The news comes as roughly 150 million taxpayers prepare to file returns by the April 15 deadline.
The administration has stopped publishing daily numbers, and Trump officials said they will release the data on a monthly basis to conserve resources.
A judge on Wednesday lifted his pause on the federal government’s deferred resignation program, prompting the Trump administration to swiftly declare victory as it closed the offer to any more workers who might still have been mulling it.
President-elect Donald Trump is expected to sign “dozens and dozens” of orders that will launch some 200 executive actions after being sworn in Monday.
President Joe Biden’s decision to block Nippon Steel’s proposed purchase of U.S. Steel was a political act made in “clear violation of due process and the law,” the two companies said Friday
The net neutrality issue revolves around how heavily federal regulators should control the companies that build and operate the internet. Democrats favor heavier oversight along the lines of how traditional telephone networks are regulated, while Republicans have argued for a lighter touch.
Supreme Court Chief Justice John Roberts on Tuesday warned that judges nationwide are under increasing threat from violence, intimidation, disinformation and officials threatening to defy lawful court decisions.
Far-right activists clashed online with billionaire Elon Musk and other supporters of President-elect Donald Trump over the need for a skilled-worker immigration program that has long been a lifeblood for Silicon Valley—signifying a potential rift between Trump’s core nationalist base and technology executives who have come to support him.
The Consumer Financial Protection Bureau announced Thursday that it has finalized new rules limiting the fees that banks can charge when customers overdraw their accounts.
A bill that would create dozens of new federal judgeships across the country received final approval in Congress on Thursday morning, setting up a likely veto from President Joe Biden even as his administration pushes to confirm his final nominees to fill existing judicial vacancies.
The ruling came Friday in a closely watched case that followed last year’s Supreme Court decision rejecting the use of affirmative action in college admissions.
The Federal Trade Commission is planning to launch an investigation into Microsoft’s cloud software business over alleged anticompetitive practices, as the Democratic-led agency tries to cement a legacy of aggressive regulation during President Joe Biden’s final weeks in office.
The Federal Trade Commission lawsuit accuses Facebook owner Meta of holding an illegal monopoly over social media.
The Department of Government Efficiency, led by Elon Musk and Vivek Ramaswamy, will provide recommendations to slash regulations, cut staff and overhaul federal operations.
The video-sharing app faces a January deadline to find a new owner not based in China or lose access to U.S. users, under a law passed in April with bipartisan support.
Minority- and women-owned businesses are bracing for the end of affirmative action in federal contracting—and the potential loss of contracts worth at least $70 billion a year.
The U.S. Food and Drug Administration, after intense public pressure and a lawsuit, is reconsidering its declaration barely two weeks ago that a shortage of the appetite-suppressing drugs Mounjaro and Zepbound—both made by Indianapolis-based Eli Lilly and Co.—is over, a temporary about-face that will allow pharmacies to keep selling unbranded copies.